Navigation Links
GenVec to Host First Quarter 2011 Earnings Call and Webcast
Date:5/3/2011

GAITHERSBURG, Md., May 3, 2011 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVCD) announced that it will release financial results for the first quarter ended March 31, 2011 on Monday, May 9, 2011 after market close.  GenVec will hold a conference call at 10:00 a.m. EDT on Tuesday, May 10, 2011 to discuss the company's first quarter financial results and business outlook.

To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980 (international) and use the following Conference ID: 63890121. An audio replay of the conference call will be available starting at 1:00 p.m. EDT on May 10, 2011 through May 17, 2011. To listen to the audio replay, dial 800-642-1687 or 706-645-9291 and use Conference Replay ID: 63890121.

A live webcast of the conference call will be available on the Company's website and will be archived for 30 days. To access the webcast or the replay, go to www.genvec.com, click on "Investor Relations," and click on "Webcasts and Data."

About GenVec

GenVec, Inc. is a biopharmaceutical company using superior, proprietary technology to create differentiated vaccines and therapeutics that are developed and commercialized through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the US Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss, balance disorders, and cancer; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), HSV-2, dengue fever, influenza, HIV, malaria, and foot-and-mouth disease. Additional information about GenVec is available at www.genvec.com and in the Company's various filings with the Securities and Exchange Commission.

Investor and Media Contact:
GenVec, Inc.
Douglas J. Swirsky
(240) 632-5510
dswirsky@genvec.com


'/>"/>
SOURCE GenVec, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GenVec Reports Fourth Quarter and 2010 Year-End Financial Results
2. GenVec Forms Collaboration With World-Leading Animal Health Company
3. GenVec Reports Third Quarter 2010 Financial Results
4. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
5. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
6. GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
7. Boston Scientific Announces CE Mark Approval and First Use of Blazer™ Open-Irrigated Catheter in Europe
8. Rigel Announces First Quarter Financial Results
9. Henry Schein Reports Record First Quarter Results
10. Regeneron Reports First Quarter 2011 Financial and Operating Results
11. Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2019)... (PRWEB) , ... January 15, 2019 , ... ... a Double Board-Certified, Ivy League-educated and fellowship-trained Facial Plastic and Reconstructive Surgeon ... Facial Plastic, Reconstructive & Laser Surgery in California, Dr. Ransom serves patients with ...
(Date:1/15/2019)... (PRWEB) , ... January 15, 2019 , ... ... have a documented penicillin allergy in their medical record, studies have shown that ... treatment outcomes and reducing the risk of infection with dangerous resistant pathogens such ...
(Date:1/14/2019)... , ... January 14, 2019 , ... ... of grants, totaling $665,400, to 16 U.S.-based 501(c)(3) nonprofits that align with its ... all, and aid for those affected by natural disasters. Located in Arizona, California, ...
Breaking Medicine Technology:
(Date:1/14/2019)... LOS ANGELES (PRWEB) , ... January 14, 2019 ... ... brand of dietary supplements, household and personal-care products with a presence worldwide, today ... key markets in 2018. Measured year-over-year, Modere sales grew by double-digits in North ...
(Date:1/14/2019)... ... , ... Proudly Presents All Reviewed & Approved Living Well Providers of 2019. , Acupuncture, ... Dr. Edward Izrailov - Maplewood , Dr. Joanna Jodar - Somerset , Dr. ... Lenahan - Point Pleasant , Dr. Robert J. Reinhardt - Pequannock , Dr. ...
(Date:1/13/2019)... ... ... , IL Top Docs Include: , ANESTHESIOLOGY, Dr. Adam Block ... Dr. Marcie Claybon , NEPHROLOGY, Dr. Naila Ahmed ... Dr. Aarathi Cholkeri-Singh , PEDIATRICS, ...
(Date:1/11/2019)... ... January 11, 2019 , ... Women’s ... station, WJR-760. , Dr. Jonathan Zaidan, President of Women’s Excellence, will co-host WJR’s ... third Wednesday of each month at 7pm. , "We are excited to partner ...
(Date:1/10/2019)... ... 10, 2019 , ... The Karis Group, an Austin, Texas based company, announced ... Executive Officer effective immediately. Mr. Jiwa succeeds the past Chief Executive Officer, Mike ... The transition was announced as part of an orderly succession plan and transition of ...
Breaking Medicine News(10 mins):